Skip to main content

Table 2 Multivariate analysis of risk factors for poor outcome at 6 months

From: Early and persistent high level of PS 100β is associated with increased poor neurological outcome in patients with SAH: is there a PS 100β threshold for SAH prognosis?

Variables

Odds ratio (95 % confidence interval)

p value

SAPS II

0.934 (0.877–0.994)

0.03

PS100β at day 5

0.051 (0.003–1.029)

0.05

NSE at day 7

0.936 (0.855–1.025)

0.15

WFNS score

0.816 (0.093–7.18)

0.8

  1. SAPS simplified acute physiology score, NSE neuron specific enolase, WFNS World Federation of Neurosurgical Societies